By Monica Heger

Researchers at the Mayo Clinic are currently evaluating different sequencing platforms and capture methods to use in molecular diagnostics, with the aim of having their first sequencing-based test ready within the next year.

Nicole Hoppman-Chaney, a fellow in clinical cytogenetics at the Mayo Clinic, told In Sequence that the researchers expect their first sequencing-based test to be for the diagnosis of hereditary colorectal cancer syndromes.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.